Taking magnesium by mouth or through an IV is linked to fewer and less severe migraine headaches, with studies showing it can reduce attack frequency and improve pain relief within hours, making it a potential helpful addition to standard migraine treatments.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A high-quality systematic review and meta-analysis of RCTs with standardized magnesium dosing, outcome measures, and participant stratification by migraine subtype (with/without aura) could establish whether magnesium consistently reduces migraine frequency and severity across populations.
A systematic review and meta-analysis of at least 15 double-blind, placebo-controlled RCTs involving adults with episodic or chronic migraine, using standardized oral magnesium (600 mg/day magnesium citrate or oxide) or IV magnesium sulfate (1g over 15-60 min), measuring migraine days per month, pain intensity (VAS), and use of rescue medication over 3-6 months, with pre-specified subgroup analyses for aura status and baseline magnesium levels.
A large, long-term RCT could determine whether magnesium supplementation causally reduces migraine frequency and severity compared to placebo in a well-defined population.
A multicenter, double-blind, placebo-controlled RCT with 500+ adults diagnosed with episodic migraine (≥4 attacks/month), randomized to 600 mg/day oral magnesium citrate or placebo for 6 months, with primary outcome being reduction in monthly migraine days (measured by daily diary), secondary outcomes including pain intensity, duration, and quality-of-life scores, and serum magnesium levels measured at baseline and endpoint.
A prospective cohort study could assess whether baseline magnesium intake or serum levels predict future migraine incidence or severity over time.
A prospective cohort study following 2,000 adults aged 18-65 without chronic migraine for 5 years, measuring dietary magnesium intake via validated food frequency questionnaires and serum magnesium at baseline, and tracking migraine onset, frequency, and severity through monthly digital diaries, adjusting for confounders like stress, sleep, and caffeine intake.
A cross-sectional study could identify whether individuals with frequent migraines have lower average magnesium levels than those without, but cannot determine directionality.
A cross-sectional study measuring serum and erythrocyte magnesium levels in 300 adults with active migraine (≥4 attacks/month) and 300 age- and sex-matched controls without migraine, using standardized assays and controlling for diet, medication use, and comorbidities.
Case reports could document rare instances where magnesium supplementation dramatically improved migraine in individuals with documented hypomagnesemia, generating hypotheses for further study.
A case series of 10-20 patients with chronic migraine and confirmed serum magnesium <0.7 mmol/L who received magnesium supplementation, documenting changes in attack frequency, intensity, and serum levels over 3 months, with detailed dietary and medication logs.